DARKO ZDILAR: Open Payments
NPI 1871527903 · WATERLOO, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,903 in 105 payments from 11 companies in 2025. Trend: 2023 $1,641 · 2024 $1,672 · 2025 $1,903
Food & beverage: $1,894Education: $10
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 37 | $543 |
| ABBVIE INC. | 27 | $460 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $341 |
| Neurocrine BioSciences, Inc. | 7 | $190 |
| Axsome Therapeutics, Inc. | 4 | $86 |
| Teva Pharmaceuticals USA, Inc. | 3 | $79 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $55 |
| Alkermes, Inc. | 2 | $47 |
| Lundbeck LLC | 2 | $44 |
| Vanda Pharmaceuticals Inc. | 2 | $40 |
Products named: VRAYLAR, CAPLYTA, REXULTI, INGREZZA, ABILIFY ASIMTUFII, Auvelity, ABILIFY MAINTENA, AUSTEDO XR.
Industry payments across IA — which companies pay providers there.
